Abstract
Patients with diabetes may experience adverse outcomes related to their glycemic control when hospitalized. Continuous glucose monitoring systems, insulin-dosing software, enhancements to the electronic health record, and other medical technologies are now available to improve hospital care. Because of these developments, new approaches are needed to incorporate evolving treatments into routine care. With the goal of educating healthcare professionals on the most recent practices and research for managing diabetes in the hospital, Diabetes Technology Society hosted the Virtual Hospital Diabetes Meeting on April 24-25, 2020. Because of the coronavirus disease 2019 (COVID-19) pandemic, the meeting was restructured to be held virtually during the national lockdown to ensure the safety of the participants and allow them to remain at their posts treating COVID-19 patients. The meeting focused on (1) inpatient management and perioperative care, (2) diabetic ketoacidosis and hyperglycemic hyperosmolar state, (3) computer-guided insulin dosing, (4) Coronavirus Disease 2019 and diabetes, (5) technology, (6) hypoglycemia, (7) data and cybersecurity, (8) special situations, (9) glucometrics and insulinometrics, and (10) quality and safety. This meeting report contains summaries of each of the ten sessions. A virtual poster session will be presented within two months of the meeting.
Highlights
More than 25% of hospitalized patients have a history of diabetes and are at high risk for hospital-related complications, such as increased 30-day readmission rate and mortality.[1,2,3,4,5] Overall, the cost of hospitalizations among patients with diabetes is more than $123 billion per year in the United States.[6]
Because of the coronavirus disease 2019 (COVID-19) pandemic situation, the meeting was held virtually and one of the sessions addressed timely issues related to the management of hospitalized patients with diabetes and COVID-19 infection
The current clinical trials using commercial subcutaneous continuous glucose monitoring (CGM) systems are evaluating the use of real-time CGM data with alerts and alarms at the bedside to avoid hypoglycemia, and nursing protocols that calculate prandial and correction doses of subcutaneous insulin based upon the CGM system’s trend data in the non-intensive care unit setting
Summary
More than 25% of hospitalized patients have a history of diabetes and are at high risk for hospital-related complications, such as increased 30-day readmission rate and mortality.[1,2,3,4,5] Overall, the cost of hospitalizations among patients with diabetes is more than $123 billion per year in the United States.[6]. An exhaustive analysis of 43 659 insulin-requiring patients at seven AdventHealth hospitals over 12 months revealed that, compared to patients with controlled blood sugar, those with severe hypoglycemia had a cost $10 405 more per inpatient stay ($7.7 million, total), a length of stay of 6.6 more days, a 61.5% higher readmission rate, and a threefold higher mortality rate These findings led to the clinical implementation of several new strategies, to include personalized insulin management using an eGlycemic Management System (eGMS), defaults to basal-bolus regimens, implementation of electronic surveillance, and more aggressive training of staff around best practices. The current clinical trials using commercial subcutaneous CGM systems are evaluating the use of real-time CGM data with alerts and alarms at the bedside to avoid hypoglycemia, and nursing protocols that calculate prandial and correction doses of subcutaneous insulin based upon the CGM system’s trend data (glucose concentration, direction of change, and rate of change) in the non-intensive care unit setting
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
